To find the most relevant journal, please insert appropriate keyword to facilitate search.
Search Results: RAAIDD
Recent Advances in Anti-Infective Drug Discovery
ISSN: 2772-4344 (Print)
eISSN: 2772-4352 (Online)
Aims and Scope:Recent Advances in Anti-Infective Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. The journal is essential reading for all researchers involved in anti-infective drug design and discovery. The journal also covers recent research in fast emerging therapeutic areas/targets & therapeutic agents related to anti-infective drug discovery. All aspects related to viral or bacterial diseases including HIV, AIDS and other sexually transmitted diseases (STDs) are also included in the scope of the journal.
Editor-in-Chief:
Tianhong Dai Massachusetts General Hospital
Harvard Medical School
Boston, MA
USA
Harvard Medical School
Boston, MA
USA
Indexed in:
Portico, Scopus, OpenAire, Index Medicus, MEDLINE/PubMed, Cambridge Scientific Abstracts (CSA)/ProQuest, Ulrich's Periodicals Directory, Suweco CZ, Scilit, QOAM, PubsHub, Norwegian Register, METADEX, MediaFinder®-Standard Periodical Directory, JournalTOCs, J-Gate, Google Scholar, Genamics Journal Seek, EMBASE, EBSCO, Jisc (Formerly: SHERPA/RoMEO), Dimensions, CNKI Scholar, Chemical Abstracts Service/SciFinder, Cabell's Directory/Journalytics, CAB Abstracts, British Library... View all
Special Issues With Active Call for Papers
Submission closes on: Jul 19, 2026
Pharmacological Advances in the Diagnosis, Prevention, and Treatment of Tuberculosis.
Tuberculosis (TB) remains a major global health challenge, exacerbated by the emergence of multidrug-resistant strains and co-infections with HIV. This thematic issue aims to highlight current advances and innovations in the diagnosis, prevention, and treatment of TB, with a special emphasis on translational and pharmacological research. Contributions will cover molecular diagnostics, biomarkers, host-directed therapies, novel anti-mycobacterial agents, vaccine development, and strategies to overcome drug resistance. By bringing together original research, reviews, and expert perspectives, this... see more